Risk Factors for Falls and Neurocognitive Disorders CLSA

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated September 19, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Primary completion date: Jul 2024 to Jul 2025
    • Study completion date: Feb 2025 to Feb 2026
    v11
  3. Primary completion date: Jul 2023 to Jul 2024
    • Study completion date: Feb 2024 to Feb 2025
    v10
  4. Primary completion date: Jul 2022 to Jul 2023
    • Study completion date: Feb 2023 to Feb 2024
    v9
  5. Primary completion date: Jul 2021 to Jul 2022
    • Study completion date: Feb 2022 to Feb 2023
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Primary completion date: Jul 2020 to Jul 2021
    • Study completion date: Feb 2021 to Feb 2022
    v7
  2. Primary completion date: Oct 2019 to Jul 2020v6
  3. Start date changed from estimate of Mar 2019 to Jul 23, 2019v5 Show 5 more changesShow less
    • Primary endpoint revised
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Secondary endpoints: 5 to 1
    • Study description expanded, about 319 words
    • Site contact updated
  4. Start date: Nov 2018 to Mar 2019
    • Primary completion date: Jul 2019 to Oct 2019
    • Study completion date: Nov 2020 to Feb 2021
    v4
  5. Start date: Sep 2018 to Nov 2018
    • Primary completion date: May 2019 to Jul 2019
    • Study completion date: Sep 2020 to Nov 2020
    v3
  6. Secondary endpoints: 3 to 5v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study evaluates the association between the neurocognitive decline and falls.
Trial Details
NCT Number NCT03628768
Lead Sponsor Jewish General Hospital
Conditions
(from sponsor)		 Neurocognitive Disorders, Geriatrics
Related terms Neurocognitive Disorders
Enrollment 12,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov